CA2173594A1 - Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo - Google Patents

Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo

Info

Publication number
CA2173594A1
CA2173594A1 CA002173594A CA2173594A CA2173594A1 CA 2173594 A1 CA2173594 A1 CA 2173594A1 CA 002173594 A CA002173594 A CA 002173594A CA 2173594 A CA2173594 A CA 2173594A CA 2173594 A1 CA2173594 A1 CA 2173594A1
Authority
CA
Canada
Prior art keywords
vivo
bioreactor
compositions
methods
hollow fiber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002173594A
Other languages
French (fr)
Other versions
CA2173594C (en
Inventor
H. David Humes
Deborah A. Cieslinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
H. David Humes
Deborah A. Cieslinski
The Regents Of The University Of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. David Humes, Deborah A. Cieslinski, The Regents Of The University Of Michigan filed Critical H. David Humes
Priority to CA2469481A priority Critical patent/CA2469481C/en
Publication of CA2173594A1 publication Critical patent/CA2173594A1/en
Application granted granted Critical
Publication of CA2173594C publication Critical patent/CA2173594C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0687—Renal stem cells; Renal progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/022—Artificial gland structures using bioreactors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00—Bioreactors or fermenters specially adapted for specific uses
    • C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/06—Tubular
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/02—Membranes; Filters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/04—Filters; Permeable or porous membranes or plates, e.g. dialysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/16—Hollow fibers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/25—Urinary tract cells, renal cells
    • C12N2502/256—Renal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/28—Vascular endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Abstract

A novel cell seeded hollow fiber bioreactor is described as a potential bioartifical kidney. Renal cells are seeded along a hollow fiber (10) in a perfused bioreactor to reproduce the ultrafiltration function and transport function of the kidney.
Maintenance of tissue specific function and ultrastructure suggest that this bioreactor provides an economical device for treating renal failure as well as studying renal tubululogenesis in vitro.
CA002173594A 1993-10-08 1994-10-11 Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo Expired - Fee Related CA2173594C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2469481A CA2469481C (en) 1993-10-08 1994-10-11 Growing renal tubule cells and ex vivo renal tubule tissue system

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/133,436 US5549674A (en) 1992-03-02 1993-10-08 Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US133,436 1993-10-08
PCT/US1994/011384 WO1995011048A2 (en) 1993-10-08 1994-10-11 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA2469481A Division CA2469481C (en) 1993-10-08 1994-10-11 Growing renal tubule cells and ex vivo renal tubule tissue system

Publications (2)

Publication Number Publication Date
CA2173594A1 true CA2173594A1 (en) 1995-04-27
CA2173594C CA2173594C (en) 2004-09-07

Family

ID=22458619

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2710965A Expired - Fee Related CA2710965C (en) 1993-10-08 1994-10-11 Growing renal tubule cells and ex vivo renal tubule tissue system
CA002173594A Expired - Fee Related CA2173594C (en) 1993-10-08 1994-10-11 Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2710965A Expired - Fee Related CA2710965C (en) 1993-10-08 1994-10-11 Growing renal tubule cells and ex vivo renal tubule tissue system

Country Status (8)

Country Link
US (2) US5549674A (en)
EP (1) EP0746343B1 (en)
JP (2) JP3614853B2 (en)
AT (1) ATE257018T1 (en)
AU (1) AU692191B2 (en)
CA (2) CA2710965C (en)
DE (1) DE69433464T2 (en)
WO (1) WO1995011048A2 (en)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410320B1 (en) 1992-03-02 2002-06-25 The University Of Michigan Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
SE9900043D0 (en) * 1999-01-11 1999-01-11 Astra Ab New use
AU2399495A (en) * 1994-04-29 1995-11-29 W.L. Gore & Associates, Inc. Improved blood contact surfaces using endothelium on a subendothelial extracellular matrix
US6152141A (en) * 1994-07-28 2000-11-28 Heartport, Inc. Method for delivery of therapeutic agents to the heart
WO1997012960A2 (en) * 1995-10-06 1997-04-10 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system
WO1998009582A1 (en) * 1996-09-05 1998-03-12 Children's Medical Center Corporation Prosthetic kidney and its use for treating kidney disease
US6673339B1 (en) 1996-09-05 2004-01-06 Children's Medical Center Corporation Prosthetic kidney and its use for treating kidney disease
US6150164A (en) * 1996-09-30 2000-11-21 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US5902336A (en) * 1996-10-15 1999-05-11 Mirimedical, Inc. Implantable device and method for removing fluids from the blood of a patient method for implanting such a device and method for treating a patient experiencing renal failure
ATE248615T1 (en) * 1997-10-31 2003-09-15 Childrens Medical Center BLADDER RECONSTRUCTION
DE69834836T2 (en) 1997-10-31 2007-05-16 Children's Medical Center Corp., Boston PENIS RECONSTRUCTION
WO2000061630A1 (en) * 1999-04-08 2000-10-19 President And Fellows Of Harvard College Induction of kidney tubule formation
JP4347528B2 (en) * 1999-04-23 2009-10-21 ネフリオン， インコーポレイテッド Extracorporeal circuit and related methods
AU2004201641B2 (en) * 1999-04-30 2007-04-19 The Charles Stark Draper Laboratory, Inc. Fabrication of Vascularized Tissue Using Microfabricated Two-Dimensional Molds
JP2002542883A (en) 1999-04-30 2002-12-17 マサチューセッツ ジェネラル ホスピタル Processing of neovascularized tissue using microfabricated two-dimensional mold
US7759113B2 (en) 1999-04-30 2010-07-20 The General Hospital Corporation Fabrication of tissue lamina using microfabricated two-dimensional molds
US20040167634A1 (en) * 1999-05-26 2004-08-26 Anthony Atala Prosthetic kidney and its use for treating kidney disease
JP3229599B2 (en) * 1999-06-01 2001-11-19 ホスパル株式会社 Blood purification device and artificial kidney using it
EP1206284B1 (en) * 1999-08-10 2007-07-11 Innovata PLC Method for delivery of therapeutic agents using a solution of dextrin
DE19943205C1 (en) * 1999-09-10 2000-11-16 Geesthacht Gkss Forschung Production, transport and elimination of biochemical substances using an apparatus comprising cells immobilized in polar orientation between two membranes, e.g. for use as a biohybrid organ
US6479064B1 (en) 1999-12-29 2002-11-12 Children's Medical Center Corporation Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
US6924141B2 (en) * 2000-03-31 2005-08-02 The General Hospital Corporation Methods of modulating hair growth
US7776021B2 (en) * 2000-04-28 2010-08-17 The Charles Stark Draper Laboratory Micromachined bilayer unit for filtration of small molecules
EP2044965B1 (en) * 2000-10-12 2012-12-19 Renal Solutions, Inc. Apparatus for body fluid flow control in extracorporeal fluid treatments
US6538010B1 (en) * 2000-11-08 2003-03-25 Research Triangle Institute Compounds and methods for promoting smoking cessation
US7033498B2 (en) * 2000-11-28 2006-04-25 Renal Solutions, Inc. Cartridges useful in cleaning dialysis solutions
US6627164B1 (en) * 2000-11-28 2003-09-30 Renal Solutions, Inc. Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
WO2002055136A2 (en) * 2000-12-01 2002-07-18 Nephros Therapeutics Inc Intrasvascular drug delivery device and use therefor
US6659973B2 (en) * 2001-01-04 2003-12-09 Transvivo, Inc. Apparatus and method for in-vivo plasmapheresis using periodic backflush
US7476210B2 (en) * 2001-01-04 2009-01-13 Transvivo Inc. Apparatus and method for in-vivo plasmapheresis using periodic backflush containing anticoagulant
US6582955B2 (en) * 2001-05-11 2003-06-24 Spectrum Laboratories, Inc. Bioreactor with application as blood therapy device
KR100864648B1 (en) * 2001-05-17 2008-10-23 가부시키가이샤 가네카 Artificial kidney having function of metabolizing protein and method of constructing the same
US6653131B2 (en) * 2001-08-30 2003-11-25 The Regents Of The University Of Michigan Method of treating systemic inflammatory response syndrome
US7332330B2 (en) * 2001-09-11 2008-02-19 Renamed Biologics, Inc. Device for maintaining vascularization near an implant
AU2002340463A1 (en) * 2001-11-16 2003-06-10 Children's Medical Center Corporation Augmentation of organ function
US6878283B2 (en) * 2001-11-28 2005-04-12 Renal Solutions, Inc. Filter cartridge assemblies and methods for filtering fluids
US7514075B2 (en) * 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
WO2006075986A1 (en) * 2005-01-10 2006-07-20 Macropore Biosurgery, Inc. Devices and methods for monitoring, managing, and servicing medical devices
CN1630526B (en) 2001-12-07 2010-05-05 马克罗珀尔生物外科公司 Systems and methods for treating patients with processed lipoaspirate cells
US20050008626A1 (en) * 2001-12-07 2005-01-13 Fraser John K. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US7651684B2 (en) 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US7595043B2 (en) * 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
US7585670B2 (en) * 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US8404229B2 (en) * 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
US20050048036A1 (en) * 2001-12-07 2005-03-03 Hedrick Marc H. Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
US7442546B2 (en) * 2002-03-15 2008-10-28 The Regents Of The University Of Michigan Method of modulating inflammatory response
EP1545749A4 (en) * 2002-09-11 2009-03-18 Univ Michigan Ultrafiltration membrane, device, bioartificial organ and methods
WO2004065616A2 (en) 2003-01-16 2004-08-05 The General Hospital Corporation Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
US7960166B2 (en) 2003-05-21 2011-06-14 The General Hospital Corporation Microfabricated compositions and processes for engineering tissues containing multiple cell types
US7998101B2 (en) * 2003-07-28 2011-08-16 Renal Solutions, Inc. Devices and methods for body fluid flow control in extracorporeal fluid treatment
AU2004269409A1 (en) * 2003-08-29 2005-03-10 Regents Of The University Of Minnesota Kidney derived stem cells and methods for their isolation, differentiation and use
JP2007530016A (en) * 2004-02-27 2007-11-01 ザ ジェネラル ホスピタル コーポレーション Methods and compositions for hair growth
DE102004017476B4 (en) * 2004-04-08 2009-03-26 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Process for the preparation of a cell composition containing epithelial cells
EP1778834B9 (en) * 2004-07-01 2011-11-09 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of renal diseases and disorders
US7083653B2 (en) * 2004-08-12 2006-08-01 Charles Edward Jennings Implantable human kidney replacement unit
US9427496B2 (en) 2005-02-18 2016-08-30 Drexel University Method for creating an internal transport system within tissue scaffolds using computer-aided tissue engineering
US7874998B2 (en) * 2005-11-04 2011-01-25 The Regents Of The University Of Michigan Filtration devices and related methods thereof
US8764697B2 (en) 2006-02-01 2014-07-01 Agathos Holdings Llc Systems and methods for an advanced medical device
US8096967B2 (en) * 2006-02-02 2012-01-17 Milan Radojicic Tissue engineered cerebrospinal fluid shunt
CA2637686A1 (en) 2006-02-02 2007-08-16 Innovative Bio Therapies An extracorporeal cell-based therapeutic device and delivery system
US8715221B2 (en) * 2006-03-08 2014-05-06 Fresenius Medical Care Holdings, Inc. Wearable kidney
US8012118B2 (en) * 2006-03-08 2011-09-06 Fresenius Medical Care Holdings, Inc. Artificial kidney dialysis system
US20080090765A1 (en) * 2006-05-25 2008-04-17 The Trustees Of Columbia University In The City Of New York Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage
US20080045611A1 (en) * 2006-08-17 2008-02-21 Milan Radojicic Methods for the therapeutic use of a carbonic anhydrase inhibitor for reducing spinal cord edema
US10478555B2 (en) 2006-08-17 2019-11-19 Milan Radojicic Systems and methods for lumbar cerebrospinal fluid access and treatment
US9770180B2 (en) * 2006-08-17 2017-09-26 Milan Radojicic System and method for monitoring and delivering therapeutics to the spinal cord
DE102006042732B3 (en) * 2006-09-12 2008-04-10 Gerlach, Jörg, Dr.med. Artificial capillary membrane system for wound treatment, comprises a capillary hollow fiber membrane system having a common inlet and outlet connected with a pumping device and a fluid media feed pump arranged in the capillary system
WO2008060788A2 (en) 2006-10-11 2008-05-22 The General Hospital Corporation Compositions, methods, and devices for treating liver disease
JP4672632B2 (en) * 2006-10-17 2011-04-20 学校法人東海大学 Bioartificial glomerulus
JP5166275B2 (en) * 2006-10-17 2013-03-21 学校法人東海大学 Bioartificial tubule
EP2125171A4 (en) 2007-01-10 2012-05-16 Univ Michigan Ultrafiltration membrane, device, bioartificial organ, and related methods
WO2008109668A2 (en) * 2007-03-05 2008-09-12 Caridianbct, Inc. Methods to control cell movement in hollow fiber bioreactors
US10590391B2 (en) * 2007-06-08 2020-03-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
AU2008262333B2 (en) * 2007-06-08 2014-07-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
CA2728215A1 (en) 2008-06-18 2010-06-24 Innovative Biotherapies, Inc. Methods for enhanced propagation of cells
US9463276B2 (en) 2008-08-16 2016-10-11 Milan Radojicic Systems and methods for a computational medical device in dynamic body systems
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
EP2177603A1 (en) 2008-09-25 2010-04-21 Gambro Lundia AB Device for renal cell expansion
EP2168668A1 (en) 2008-09-25 2010-03-31 Gambro Lundia AB Membrane for cell expansion
EP2168666A1 (en) 2008-09-25 2010-03-31 Gambro Lundia AB Irradiated membrane for cell expansion
ATE545440T1 (en) 2008-09-25 2012-03-15 Gambro Lundia Ab HYBRID BIOLOGICAL ARTIFICIAL KIDNEY
EP2344220B1 (en) * 2008-11-03 2013-04-24 Fresenius Medical Care Holdings, Inc. Portable peritoneal dialysis system
WO2010052705A1 (en) * 2008-11-06 2010-05-14 Morris Laster Blood filtering device and method
CN102271692B (en) * 2008-11-12 2014-05-21 坦吉恩股份有限公司 Isolated renal cells and uses thereof
WO2010057015A1 (en) * 2008-11-14 2010-05-20 Wake Forest University Health Sciences Kidney structures and methods of forming the same
US20110236874A1 (en) * 2008-12-02 2011-09-29 Daniele Zink Method for formation of renal tubules
WO2010127310A1 (en) 2009-05-01 2010-11-04 Cytori Therapeutics, Inc. Systems, methods and compositions for optimizing tissue and cell enriched grafts
WO2011140231A1 (en) 2010-05-05 2011-11-10 Caridianbct, Inc. Method of reseeding adherent cells grown in a hollow fiber bioreactor system
WO2011143499A1 (en) 2010-05-12 2011-11-17 Tengion, Inc. Bioactive renal cells
EP2412798A1 (en) * 2010-07-27 2012-02-01 Gambro Lundia AB Biomimetic membrane for cell expansion
EP2625264B1 (en) 2010-10-08 2022-12-07 Terumo BCT, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
WO2012057701A1 (en) * 2010-10-25 2012-05-03 Agency For Science, Technology And Research Tubular fiber membrane with nanoporous skin
CN103298498B (en) 2010-11-10 2017-12-08 因瑞金公司 Ejection preparation for organ enhancing
AU2012271341B2 (en) 2011-06-15 2017-07-13 The Charles Stark Draper Laboratory, Inc. Systems, methods, and devices relating to a biomimetic cellularized nephron unit
EP2797645B1 (en) 2011-12-28 2017-10-18 Xerem Medical Ltd. System and method for blood filtering and/or treatment
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
US20160090569A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled Feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
CN105457118B (en) * 2015-12-17 2018-01-02 珠海健帆生物科技股份有限公司 Apparatus for purifying blood and system
CN105733944A (en) * 2016-05-04 2016-07-06 浙江大学 Construction method for six-pore plate hepatic cell hollow fiber reactor
EP3464565A4 (en) 2016-05-25 2020-01-01 Terumo BCT, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
CN110035778B (en) * 2016-09-06 2022-01-21 哈佛大学的校长及成员们 Living device, method and use for replacing or specifying organ functions
US11052230B2 (en) 2016-11-08 2021-07-06 W. L. Gore & Associates, Inc. Implantable encapsulation devices
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
US11629332B2 (en) 2017-03-31 2023-04-18 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2019198674A1 (en) * 2018-04-13 2019-10-17 日機装株式会社 Cell culture method, method for producing cell support complex, cultured cell and cell support complex
WO2023210765A1 (en) * 2022-04-28 2023-11-02 株式会社クラレ Immunoisolation device

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3734851A (en) * 1969-12-29 1973-05-22 K Matsumura Method and device for purifying blood
CA1027304A (en) * 1973-06-06 1978-03-07 Theodore E. Spielberg Artificial gland structure
US4242460A (en) * 1978-12-26 1980-12-30 Chick William L Cell culture device
EP0058275A1 (en) * 1981-02-17 1982-08-25 SENKO MEDICAL INSTRUMENT Mfg Co., LTD Hollow fiber artificial kidney
US4354933A (en) * 1981-02-23 1982-10-19 Lester James P Implantable artificial kidney
JPS61115569A (en) * 1984-11-09 1986-06-03 テルモ株式会社 Artificial kidney and its production
US5035708A (en) * 1985-06-06 1991-07-30 Thomas Jefferson University Endothelial cell procurement and deposition kit
IL78950A (en) * 1985-06-06 1991-12-15 Univ Jefferson Coating for prosthetic devices
JP2739758B2 (en) * 1987-02-24 1998-04-15 ヴィレス，ジョセフ・エム Liver assist device using transformed cell line
WO1989001967A1 (en) * 1987-09-03 1989-03-09 Brown University Research Foundation Blood purification with cultured renal cells
JP2835629B2 (en) * 1989-05-18 1998-12-14 ザ リージェンツ オブ ザ ユニヴァーシティ オブ ミネソタ Bioreactor equipment
WO1991000119A1 (en) * 1989-06-30 1991-01-10 Baxter International Inc. Implantable device
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
WO1992007615A1 (en) * 1990-10-29 1992-05-14 Regents Of The University Of Minnesota A bioartificial liver
US5429938A (en) * 1992-03-02 1995-07-04 University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules

Also Published As

Publication number Publication date
ATE257018T1 (en) 2004-01-15
JP3614853B2 (en) 2005-01-26
JP2004267795A (en) 2004-09-30
CA2710965A1 (en) 1995-04-27
CA2173594C (en) 2004-09-07
AU692191B2 (en) 1998-06-04
WO1995011048A3 (en) 1995-06-22
EP0746343B1 (en) 2004-01-02
EP0746343A1 (en) 1996-12-11
WO1995011048A2 (en) 1995-04-27
DE69433464D1 (en) 2004-02-05
AU7970194A (en) 1995-05-08
EP0746343A4 (en) 1997-12-03
JP3795900B2 (en) 2006-07-12
US5549674A (en) 1996-08-27
CA2710965C (en) 2012-10-09
US5686289A (en) 1997-11-11
DE69433464T2 (en) 2004-11-11
JPH09503941A (en) 1997-04-22

Similar Documents

Publication Publication Date Title
CA2173594A1 (en) Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
NO20001509D0 (en) Formation of hematopoietic cells from multipotent neutral stem cells
DE59309926D1 (en) Module for breeding and using metabolic performance and / or for maintaining microorganisms
ATE162385T1 (en) WATER WITHDRAWAL WITH HYDROGEL
AU2900792A (en) Neomorphogenesis of urological structures in vivo from cell culture
AU641488B2 (en) Human hematopoietic stem cell
CA2244659A1 (en) Biological reactor for the cultivation of cells
DK0469070T3 (en) Neomorphogenesis of cartilage in vivo from cell culture
EP0599651A3 (en) Bioreactor for the perfusion culture of cells.
NZ290629A (en) Controlling growth of cells within bioartificial organ
ES2070926T3 (en) SUPPRESSION OF CELL PROLIFERATION THROUGH DECORIN.
AU2387795A (en) Culture medium for maintaining viability of mammalian cells
CA2146734A1 (en) Method for long term subculture of dermal papilla cells
AU3806695A (en) Biomaterial containing epithelial cells and use thereof as a transplant
WO1999029279A3 (en) Long-term survival and regeneration of central nervous system neurons
AU7937491A (en) Permeable membrane excellent in biocompatibility
ZA917561B (en) Media for culture of mammalian cells
DE3666458D1 (en) Method and device for the _i(in vitro) culture of plant cells and organs, as well as for the micropropagation and regeneration of complete plants
DK0563256T3 (en) Use of host cell phospholipids to inhibit bacterial colonization
AU8193391A (en) Photobioreactors and closed ecological life support systems and artificial lungs containing the same
FR2691875B1 (en) Modular growing media and their domestic use.
DE3854472T2 (en) Maintenance of the viability of microorganisms for use in microbial inoculants.
FR2554124B1 (en) CONTAINER FOR "IN VITRO" CULTURE OF FABRIC CELLS, PLANT ORGANS AND PLANTS
FR2735146B1 (en) PROCESS FOR CULTURING MARINE INVERTEBRA CELLS AND CULTURES OBTAINED
PL285546A1 (en) Biological culture medium for cell cultures and method of culturing human keratocytes as well as proteinous concentrate

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20141014